dr. ali on adjuvant studies with biosimilars in oncology
Published 5 years ago • 66 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
0:19
copy of dr. ali on adjuvant studies with biosimilars in oncology
-
0:50
dr. ali on whether biosimilars can replace biologics in oncology
-
2:04
dr. ali on incorporating biosimilars into cancer treatment
-
1:48
dr. markman on the concept of biosimilars in oncology
-
5:59
dr ali mcbride discusses the role of biosimilars in oncology
-
3:33
biosimilars: manufacturing and inherent variation
-
4:20
the biosimilar development process
-
44:08
15-years of biosimilars in europe: what lessons can we share? - panel 1
-
0:19
copy of dr. ali on incorporating biosimilars into cancer treatment
-
1:29
dr. ali on the future of adjuvant care for her2 breast cancer
-
0:46
dr. ali explains misconceptions about biosimilars
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
7:22
an overview of biosimilarity
-
5:58
the availability of multiple biosimilars for 1 biologic
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
1:21
dr. denes discusses biosimilar pricing in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:56
dr. kolberg on ensuring confidence with biosimilars in oncology
-
20:06
biologics and biosimilars: extrapolation of indications – information for healthcare providers
-
5:56
the complexity of choosing biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology